Back to results
US 2024/0181009 A1Published application
Synthekine compositions and methods of use
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsIgnacio Moraga Gonzalez, Kenan Christopher Garcia
Life of this patent
Estimating the term…
Abstract
Engineered synthekines and methods of use thereof are provided.
Claims20
1-23. (canceled)
A synthetic ligand polypeptide comprising:
- at least two binding domains, wherein each binding domain specifically binds to the extracellular domain of a cytokine receptor polypeptide subunit expressed on the surface of a cell;
- wherein:
- the first binding domain is a first monovalent antibody that specifically binds to the extracellular domain of a first cytokine receptor subunit, wherein the first cytokine receptor subunit has an intracellular domain comprising at least one JAK/STAT binding sequence;
- and
- the second binding domain is a second monovalent antibody that specifically binds to the extracellular domain of a second cytokine receptor subunit, wherein the second cytokine receptor subunit has an intracellular domain comprising at least one JAK/STAT binding sequence,
- wherein the first and second cytokine receptor subunits do not naturally multimerize in response to contacting the cell with a naturally occurring cytokine ligand;
- and
- wherein contacting the cell expressing the first and second cytokine receptor subunits results in multimerization of the cytokine receptor subunits and activation of a JAK/STAT-mediated signal in the cell;
- and
- wherein the first and second binding domains are covalently linked through a polypeptide linker.
7 more elements
Dependencies are inferred from the claim text.